scorecardresearch
Add as a preferred source on Google
Sunday, November 30, 2025
TopicCovid vaccines

Topic: Covid vaccines

Covid pandemic — Protests in France against ‘health pass’, New Zealand extends lockdown

ThePrint brings you some important global stories on the coronavirus pandemic.

India to have 18-22 crore vaccine doses by September, ZyCoV D could take longer to hit market

The increase in vaccine procurement is good news in terms of daily vaccination numbers, but govt's stated target of 1 crore daily vaccinations still some time away.

Zycov D is 66% effective against Delta variant of SARS-Cov-2, claims Zydus Cadila

Zydus' claim comes a day after it being given emergency use authorisation in India, and is the only vaccine approved for use in 12-18 years age group.

Covid vaccines for children could be available by September, Bharat Biotech & NIV say

Bharat Biotech CMD Dr Krishna Ella said final phase of clinical trial is over & they hope to get licence soon. NIV Director Dr Priya Abraham said vaccines may be available by Sept.

Covid vaccines less effective against Delta variant, UK study finds

The study results may fuel calls to give booster shots to the fully vaccinated. While UK is still deciding, US says those who got both doses will get a third shot after 8 months.

Covid cases in Southeast Asia plateaued over past month as India’s tally remained stable: WHO

South-East Asia Region reported over 799,000 new cases, a 5% decrease from last week, however, some countries in the Region continue to report a rise, including Sri Lanka, Thailand.

No clarity on India launch of single-dose J&J Covid jab as talks focus on indemnity hurdle

US pharmaceutical companies like Moderna, Pfizer and Johnson & Johnson have asked for indemnity against legal liability but the Government of India has not been inclined to give it.

Facilities at Bharat Biotech to be augmented to increase Covaxin supply, Mandaviya says

In a written reply to Rajya Sabha Friday, Health Minister Mansukh Mandaviya said that three Public Sector Enterprises will also be supported to manufacture Covaxin.

India unlikely to give indemnity to foreign vaccines, may consider only if shortage persists

Modi govt is not inclined to give Moderna or any other foreign vaccine manufacturer indemnity as long as the vaccine programme's target seems achievable by current supply.

Biden’s US promised Covid vaccines for India but here’s why they may never arrive

Covid vaccine talks between India and US seem to have reached a dead-end in the absence of consensus over indemnity issues.

On Camera

‘Delhi winters’ is a legend. Now it’s just air anxiety

The wealthy float above the crisis—insulated in air-purified cars, weekend getaways at farmhouses, and vacations timed perfectly to coincide with Delhi’s worst weeks.

Karnataka startups feel the chill as global funding winter sets in. Fintech emerges as sole bright spot

The state raises just $2.7 billion in first nine months of 2025 compared to $4.5 billion last year, with late-stage investments hit hardest.

What’s expected from Putin’s India visit in December—Defence Secretary explains

ThePrint had previously reported that India & Russia are talking about 5 more regiments of the S-400, but no contracts are to be signed during the Russian president's visit.

Gaali cricket: Bavuma stands tall, India’s Test ego cut to size

The India-South Africa series-defining fact is the catastrophic decline of Indian red ball cricket where a visiting team can mock us with the 'grovel' word.